إعلان
إعلان

DNA

DNA logo

Ginkgo Bioworks Holdings, Inc.

9.29
USD
برعاية
+0.22
+2.48%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

9.32

+0.04
+0.38%

تقارير أرباح DNA

النسبة الإيجابية المفاجئة

DNA تفوق 6 من 17 آخر التقديرات.

35%

التقرير التالي

بيانات التقرير القادم
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q-- -1 (Revenue/ EPS)
--
/
--

Ginkgo Bioworks Holdings, Inc. earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, DNA reported earnings of -1.45 USD per share (EPS) for Q3 25, missing the estimate of -1.25 USD, resulting in a -15.78% surprise. Revenue reached 38.84 مليون, compared to an expected 39.24 مليون, with a -1.02% difference. The market reacted with a -20.80% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Ginkgo Bioworks Holdings, Inc. reported EPS of -$1.45, missing estimates by -15.78%, and revenue of $38.84M, -1.02% below expectations.
The stock price moved down -20.8%, changed from $11.30 before the earnings release to $8.95 the day after.
The next earning report is scheduled for --.
Based on -- المحللين, Ginkgo Bioworks Holdings, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان